Literature DB >> 18695981

Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients.

Jadranka Morovic-Vergles1, Melanie Ivana Culo, Stjepan Gamulin, Filip Culo.   

Abstract

The relationship between synovial fluid (SF) cAMP level and IL-18 and PGE2 SF levels in rheumatoid arthritis (RA) and osteoarthritis (OA) patients, and between SF cAMP level and disease as well as inflammatory activity in RA were investigated in 17 RA and 19 OA patients. Erythrocyte sedimentation rate (ESR), serum (S) C-reactive protein (CRP) level and SF IL-18 level were higher in RA than in OA patients. SF PGE2 level was similar in both groups. SF cAMP level was higher in OA than in RA patients. In RA patients, SF cAMP level showed negative correlation with Disease Activity Score including a 28-joint count and S CRP, ESR and SF IL-18 level. The results suggest that cAMP promotes anti-inflammatory response in RA and OA patients, which is higher in the latter. Promotion of anti-inflammatory response by cAMP elevating agents might be useful in the treatment of RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695981     DOI: 10.1007/s00296-008-0663-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  Plasma and synovial fluid cAMP in patients with rheumatoid arthritis.

Authors:  S Wadskov; R Donde; J Sylvest
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

Review 2.  Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.

Authors:  Hedi Harizi; Norbert Gualde
Journal:  Cell Mol Immunol       Date:  2006-08       Impact factor: 11.530

3.  Pathomechanisms in rheumatoid arthritis--time for a string theory?

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 4.  Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy.

Authors:  Jun Akaogi; Toshiko Nozaki; Minoru Satoh; Hidehiro Yamada
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2006-12       Impact factor: 2.895

5.  Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial.

Authors:  M Goto; T Hanyu; T Yoshio; H Matsuno; M Shimizu; N Murata; S Shiozawa; T Matsubara; S Yamana; T Matsuda
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

6.  A proinflammatory role for IL-18 in rheumatoid arthritis.

Authors:  J A Gracie; R J Forsey; W L Chan; A Gilmour; B P Leung; M R Greer; K Kennedy; R Carter; X Q Wei; D Xu; M Field; A Foulis; F Y Liew; I B McInnes
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Cyclic nucleotides in joint fluid in rheumatoid arthritis and in Reiter's syndrome.

Authors:  L E Trang; O Lövgren; A E Roch-Norlund; R S Horn; O Walaas
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

Review 8.  Cyclooxygenase-2 and prostaglandins in articular tissues.

Authors:  Johanne Martel-Pelletier; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Semin Arthritis Rheum       Date:  2003-12       Impact factor: 5.532

9.  Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.

Authors:  E Seppälä; M Nissilä; H Isomäki; P Nuotio; E Nykänen; O Laitinen; H Vapaatalo
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

10.  Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.

Authors:  P Bertin; F Lapicque; E Payan; M Rigaud; F Bailleul; S Jaeger; R Treves; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more
  5 in total

1.  Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis.

Authors:  Batool Zamani; Raika Jamali; Hassan Ehteram
Journal:  Rheumatol Int       Date:  2010-08-19       Impact factor: 2.631

2.  Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.

Authors:  Ankita Singh; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2019-06-15       Impact factor: 2.631

3.  Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease?

Authors:  Jadranka Morović-Vergles; Lea Salamon; Daniela Marasović-Krstulović; Tatjana Kehler; Davorin Sakić; Olga Badovinac; Tonko Vlak; Srđan Novak; Nives Stiglić-Rogoznica; Marino Hanih; Dražen Bedeković; Simeon Grazio; Mira Kadojić; Jasminka Milas-Ahić; Višnja Prus; Doris Stamenković; Daniela Sošo; Branimir Anić; Durđica Babić-Naglić; Stjepan Gamulin
Journal:  Rheumatol Int       Date:  2012-09-11       Impact factor: 2.631

Review 4.  Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.

Authors:  Philip M Brown; Arthur G Pratt; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2016-10-27       Impact factor: 20.543

5.  Synovial Fluid Biomarkers in Knee Osteoarthritis: A Systematic Review and Quantitative Evaluation Using BIPEDs Criteria.

Authors:  Angelo Boffa; Giulia Merli; Luca Andriolo; Christian Lattermann; Gian M Salzmann; Giuseppe Filardo
Journal:  Cartilage       Date:  2020-07-25       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.